Log In
BCIQ
Print this Print this
 

Aiwen

  Manage Alerts
Collapse Summary General Information
Company China Nuokang Bio-Pharmaceutical Inc.
DescriptionIntravenous anti-arrhythmic agent
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationPeripheral vascular disease (PVD)
Indication DetailsDiagnose and treat paroxysmal supraventricular tachycardia (PSVT)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today